carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper02', 'sclc']
how to manipulate tigit inhibitors has still to be understand #asco22 results of skyscraper02 in es sclc 
CEO Gustave Roussy Cancer Campus Aix Marseille University Thoracic oncologist Cofounder Marseille Immunopole Coordinator #ThePioneeRproject Tweets are my own